Related references
Note: Only part of the references are listed.Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs
Joanna M. Wieronska et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Mood disorders: Regulation by metabotropic glutamate receptors
Andrzej Pilc et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The possible involvement of metabotropic glutamate receptors in schizophrenia
Amir Krivoy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder
Eduardo Dunayevich et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs
Agnieszka Palucha et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Metabotropic glutamate receptors
Francesco Ferraguti et al.
CELL AND TISSUE RESEARCH (2006)
Methyl substitution of 2-aminobicyclo[3.1.0]hexane 2,6-dicarboxylate (LY354740) determines functional activity at metabotropic glutamate receptors: Identification of a subtype selective mGlu2 receptor agonist
C Dominguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Detailed pharmacological characterization of 5-HT1A-receptor-mediated [35S]GTPγS binding in rat hippocampal membranes
Y Odagaki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Metabotropic glutamate 2/3 receptors as drug targets
GJ Marek
CURRENT OPINION IN PHARMACOLOGY (2004)
The [35S]GTPγS binding assay:: approaches and applications in pharmacology
C Harrison et al.
LIFE SCIENCES (2003)
Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2
H Schaffhauser et al.
MOLECULAR PHARMACOLOGY (2003)
Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor:: Synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethyl-amine
MP Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268
DS Lorrain et al.
NEUROSCIENCE (2003)
The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology
Jean-Philippe Pin et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Stimulation of high-affinity GTPase activity through group II metabotropic glutamate receptors in rat hippocampal and striatal membranes
Y Odagaki et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes
N Nishi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Functional coupling of GABA(B) receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramin, and benzalkonium chloride in rat cerebral cortical membranes
Y Odagaki et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Characterization of [H-3]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors
C Schweitzer et al.
NEUROPHARMACOLOGY (2000)
Share Paper
